Synchron CEO Tom Oxley tells CNBC’s Squawk Box Asia that the company’s brain chip implant is designed to treat motor impairments now, with plans to address mild cognitive decline in the future. He ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results